Results 181 to 190 of about 478,842 (334)

A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK‐β

open access: yesAdvanced Science, EarlyView.
This study demonstrates that the expression of A20, a ubiquitin‐editing enzyme, is positively correlated with oxaliplatin sensitivity in colorectal cancer (CRC). Mechanistically, A20 enhances oxaliplatin sensitivity by inhibiting NF‐κB nuclear translocation through monoubiquitination of IKK‐β.
Fan Luo   +12 more
wiley   +1 more source

scPER: A Rigorous Computational Approach to Determine Cellular Subtypes in Tumors Aligned With Cancer Phenotypes From Total RNA Sequencing

open access: yesAdvanced Science, EarlyView.
scPER presents an adversarial‐autoencoder framework that deconvolves bulk total RNA‐seq to quantify tumor‐microenvironment cell types and uncover phenotype‐linked subclusters. Across diverse benchmarks, scPER improves accuracy over existing tools.
Bingrui Li, Xiaobo Zhou, Raghu Kalluri
wiley   +1 more source

Primary Malignant Melanoma of the Lung With a Long-Term Course: A Case Report. [PDF]

open access: yesRespirol Case Rep
Fukushima Y   +7 more
europepmc   +1 more source

CD20+FCRL4+ B Cells Activate CD8+ T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity

open access: yesAdvanced Science, EarlyView.
CD20⁺FCRL4⁺ B cells in nasopharyngeal carcinoma actively cross‐present exogenous tumor antigens via MHC‐I, enhancing CD8⁺ T‐cell activation, memory formation, and cytotoxicity. IFNγ‐driven WDFY4 upregulation facilitates this process. These findings reveal an unconventional B‐cell–mediated antitumor mechanism and indicate potential relevance to ...
Benjian Zhang   +17 more
wiley   +1 more source

A Case of Primary Malignant Melanoma of the Nasolacrimal Duct. [PDF]

open access: yesCureus
Terazawa K   +4 more
europepmc   +1 more source

Nuclear Alpha‐Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma

open access: gold
María E. Jiménez‐Capdeville   +5 more
openalex   +1 more source

Preventive DAV therapy.The study of the preventive DAV therapy for Stage II and III malignant melanoma patients.

open access: diamond, 1991
Masako KOBAYASHI   +7 more
openalex   +2 more sources

MALIGNANT MELANOMA

open access: yesAnnals of Surgery, 1951
M, GAGE, W, DAWSON
openaire   +3 more sources

Home - About - Disclaimer - Privacy